[go: up one dir, main page]

CY1110353T1 - Ανοσορρυθμιστικοι ολιγοσακχαριτες - Google Patents

Ανοσορρυθμιστικοι ολιγοσακχαριτες

Info

Publication number
CY1110353T1
CY1110353T1 CY20091100742T CY091100742T CY1110353T1 CY 1110353 T1 CY1110353 T1 CY 1110353T1 CY 20091100742 T CY20091100742 T CY 20091100742T CY 091100742 T CY091100742 T CY 091100742T CY 1110353 T1 CY1110353 T1 CY 1110353T1
Authority
CY
Cyprus
Prior art keywords
oligosagars
immunizable
immune system
oligosaccharide
mammal
Prior art date
Application number
CY20091100742T
Other languages
English (en)
Inventor
Bernd Stahl
Laura M´Rabet
Arjan Paul Vos
Johan Garssen
Günther Boehm
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34524733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110353(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of CY1110353T1 publication Critical patent/CY1110353T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία μέθοδο για την ενίσχυση του ανοσοποιητικού συστήματος και τη θεραπευτική αντιμετώπιση και/ή την πρόληψη διαταραχών οι οποίες σχετίζονται με το ανοσοποιητικό σύστημα σε ένα θηλαστικό, όπως το Σύνδρομο της Επίκτητης Ανοσοποιητικής Ανεπάρκειας (AIDS), ιδίως σε νεογνά, η εν λόγω μέθοδος περιλαμβάνει τη χορήγηση όξινων ολιγοσακχαριτών και ουδέτερων ολιγοσακχαριτών. Παρέχονται επίσης διατροφικές συνθέσεις κατάλληλες για χρήση στην ανωτέρω μέθοδο.
CY20091100742T 2003-10-24 2009-07-14 Ανοσορρυθμιστικοι ολιγοσακχαριτες CY1110353T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03078375 2003-10-24
EP04076877 2004-06-25
EP06115301A EP1721612B1 (en) 2003-10-24 2004-10-25 Immunemodulating oligosaccharides

Publications (1)

Publication Number Publication Date
CY1110353T1 true CY1110353T1 (el) 2015-04-29

Family

ID=34524733

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20081100995T CY1108342T1 (el) 2003-10-24 2008-09-16 Ανοσορρυθμιστικοι ολιγοσακχαριτες
CY20091100742T CY1110353T1 (el) 2003-10-24 2009-07-14 Ανοσορρυθμιστικοι ολιγοσακχαριτες

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20081100995T CY1108342T1 (el) 2003-10-24 2008-09-16 Ανοσορρυθμιστικοι ολιγοσακχαριτες

Country Status (19)

Country Link
US (1) US8557794B2 (el)
EP (8) EP2123282A3 (el)
JP (1) JP4943853B2 (el)
CN (1) CN101987107A (el)
AT (2) ATE429232T1 (el)
AU (2) AU2004283628B2 (el)
BR (1) BRPI0415699A (el)
CA (1) CA2542996C (el)
CY (2) CY1108342T1 (el)
DE (2) DE602004014992D1 (el)
DK (2) DK1733730T3 (el)
ES (3) ES2324369T3 (el)
NZ (2) NZ546785A (el)
PL (2) PL1733730T3 (el)
PT (2) PT1721612E (el)
RU (2) RU2388478C2 (el)
SG (2) SG152270A1 (el)
SI (2) SI1721612T1 (el)
WO (1) WO2005039597A2 (el)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
PL1733730T3 (pl) * 2003-10-24 2008-12-31 Nutricia Nv Oligosacharydy immunomodulujące
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
JP2006298783A (ja) * 2005-04-18 2006-11-02 Nisshin Sugar Mfg Co Ltd 免疫賦活組成物
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP1745705A1 (en) * 2005-07-20 2007-01-24 N.V. Nutricia Process for preparing uronic acid oligosaccharides by extrusion
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007067033A1 (en) * 2005-12-06 2007-06-14 N.V. Nutricia Composition containing oligosaccharides for the treatment/ prevention of infections
DE602006008985D1 (de) * 2005-12-16 2009-10-15 Nutricia Nv Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
US20090297636A1 (en) * 2006-02-07 2009-12-03 Martine Sandra Alles Sensoric imprinting
RU2430631C2 (ru) * 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
ES2459621T3 (es) * 2006-03-10 2014-05-12 N.V. Nutricia Uso de sacáridos no digeribles para dar a un bebé el mejor comienzo después del nacimiento
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008010428A1 (en) * 2006-07-19 2008-01-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Immunomodulating agent
US8691213B2 (en) 2006-08-04 2014-04-08 SHS International Protein free formula
US20080089981A1 (en) † 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
JP2008247858A (ja) * 2007-03-30 2008-10-16 Hayashibara Biochem Lab Inc ダイエット用の経口摂取用組成物
NZ582329A (en) 2007-06-26 2012-09-28 Nutricia Nv Improving memory in subjects with mini-mental state examination of 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
BRPI0820956B8 (pt) 2007-12-05 2018-01-16 Nutricia Nv composição nutricional enteral líquida esterilizada, método para produzir a composição, uso de uma composição nutricional, e, uso simultâneo ou seqüencial de caseína micelar e, opcionalmente, caseinato
EP2687106B1 (en) 2007-12-05 2018-05-02 N.V. Nutricia High energy liquid enteral nutritional composition
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
PL2609812T3 (pl) 2007-12-20 2019-02-28 N.V. Nutricia Ciekły produkt zawierający nukleotydy/nukleozydy
WO2009087988A1 (ja) * 2008-01-09 2009-07-16 Nutri Co., Ltd. がん化学療法時に起こる酸化ストレス及び／又は副作用の軽減あるいはがん化学療法時の栄養状態を改善するための組成物
WO2009096772A1 (en) 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
EP2293677B1 (en) 2008-06-13 2017-11-15 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
RU2379047C1 (ru) * 2008-06-16 2010-01-20 Государственное учреждение Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской Академии медицинских наук (ГУ НИИ фармакологии ТНЦ СО РАМН) Средство, обладающее противоаллергическим действием
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
WO2010047581A1 (en) * 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
WO2010095926A1 (en) 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning
WO2010098822A1 (en) 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010104375A1 (en) 2009-03-12 2010-09-16 N.V. Nutricia Stigmasterol for the treatment of alzheimer's disease
US8293264B2 (en) 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010140877A1 (en) 2009-06-05 2010-12-09 N.V. Nutricia Liquid enteral nutritional composition with a low monovalent metal ion content
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
ES2904608T3 (es) * 2009-07-15 2022-04-05 Nutricia Nv Fucosil lactosa como oligosacárido no digerible idéntico al de la leche materna para tratar y/o prevenir la diarrea vírica
CN102497868A (zh) * 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
CN101637264B (zh) * 2009-08-20 2012-11-14 辽宁大学 低聚糖益生元
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
WO2011112075A1 (en) 2010-03-11 2011-09-15 N.V. Nutricia Controlling the texture of high-protein nutritional compositions comprising micellar casein
EP3202406A1 (en) * 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP3338565A1 (en) * 2010-06-04 2018-06-27 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2575508B1 (en) * 2010-06-04 2019-01-09 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
WO2012107095A1 (en) * 2011-02-10 2012-08-16 Alfa Biogene International B.V. Plant hsp70 for use in the treatment of food allergy
EP2526784A1 (en) * 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
WO2013012313A1 (en) 2011-07-18 2013-01-24 N.V. Nutricia Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013117234A1 (en) * 2012-02-10 2013-08-15 N.V. Nutricia Maternal composition for enhancing immune system
US20150080334A1 (en) 2012-02-10 2015-03-19 N.V. Nutricia Maternal supplement to enhance immune system of an infant
WO2013126015A1 (en) 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
WO2013129912A1 (en) 2012-02-28 2013-09-06 N.V. Nutricia Energy-rich liquid nutritional composition having improved organoleptic properties
GB201208325D0 (en) 2012-05-11 2012-06-27 Glycomar Ltd Saccharides
WO2013172714A1 (en) 2012-05-18 2013-11-21 N.V. Nutricia Treatment of conditions associated with mycotoxin exposure
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
JP5841168B2 (ja) * 2012-08-24 2016-01-13 カクイ株式会社 抗腫瘍剤
WO2014030250A1 (ja) * 2012-08-24 2014-02-27 カクイ株式会社 抗腫瘍剤
JP6160011B2 (ja) * 2013-02-06 2017-07-12 松谷化学工業株式会社 ＩｇＡ分泌促進剤
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
JP2013150635A (ja) * 2013-05-01 2013-08-08 Hayashibara Co Ltd ダイエット用の経口摂取用組成物
BR112015030767B1 (pt) 2013-06-10 2021-03-30 N.V. Nutricia Uso de uma composição
WO2015050177A1 (ja) * 2013-10-03 2015-04-09 日東電工株式会社 インフルエンザワクチン乾燥製剤、及び、インフルエンザワクチン乾燥製剤の製造方法
RU2663065C2 (ru) 2013-11-04 2018-08-01 Н.В. Нютрисиа Ферментированное детское питание с неперевариваемыми олигосахаридами
CN104055784A (zh) * 2014-06-24 2014-09-24 刘斌 一种婴幼儿用预防过敏的组合物
WO2016013928A1 (en) * 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
WO2018023003A1 (en) * 2016-07-29 2018-02-01 Isothrive Llc Optimized individualized prebiotic compositions
CN109843073A (zh) * 2016-09-19 2019-06-04 普罗莱克塔生物科学公司 经纯化的人乳低聚糖组合物
EP3711493A1 (en) * 2016-11-16 2020-09-23 Fresenius Kabi Deutschland GmbH Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
AU2018229814B2 (en) 2017-03-08 2023-06-01 N.V. Nutricia Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
WO2021007091A2 (en) * 2019-07-05 2021-01-14 Cosmevia Llc Prebiotic cosmetic compositions and methods for the preparation thereof
CN113072601B (zh) * 2021-03-30 2023-03-31 固安君德同创生物工程有限公司 一种功能性寡糖糖苷酯的制备方法及其应用
CN119677760A (zh) * 2022-12-30 2025-03-21 西吉隆医疗股份有限公司 经修饰的多糖聚合物及其相关组合物和方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839555A (en) * 1971-03-26 1974-10-01 Rit Rech Ind Therapeut Vaccine adjuvant and method
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
JPS584724A (ja) * 1981-07-01 1983-01-11 Meiji Milk Prod Co Ltd 免疫賦活剤
EP0181351A4 (en) * 1984-05-09 1989-06-21 Univ Australian METHOD FOR MODULATING IMMUNE REACTION.
JPH0714885B2 (ja) * 1986-05-20 1995-02-22 野田食菌工業株式会社 免疫活性物質
DE3921761A1 (de) 1989-07-01 1991-01-03 Hoechst Ag Substituierte polysaccharide, verfahren zu deren herstellung sowie deren verwendung zur prophylaxe und behandlung von viruserkrankungen
JPH04300888A (ja) 1991-03-28 1992-10-23 Dainippon Ink & Chem Inc カルボン酸オリゴ糖エステル硫酸化物
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
DE4223613C2 (de) 1992-07-17 1994-07-21 Zuckerindustrie Verein Verfahren zur Herstellung von ungesättigten Uroniden aus pektinhaltigen Stoffen
JP3568214B2 (ja) * 1993-03-03 2004-09-22 昭和産業株式会社 免疫賦活剤
KR970011556B1 (ko) * 1993-12-20 1997-07-12 농촌진흥청 장수버섯 추출물의 정제방법
JPH0892303A (ja) 1994-09-20 1996-04-09 Showa Sangyo Co Ltd 新規な糖、その製造方法および免疫賦活剤
JPH0948732A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
JP3850908B2 (ja) * 1996-01-30 2006-11-29 ポーラ化成工業株式会社 血糖値上昇抑制剤及びそれを含有する組成物
FR2751876B1 (fr) * 1996-07-31 1998-12-31 Roc Sa Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
KR100252194B1 (ko) * 1997-10-10 2000-04-15 박호군 참당귀에서분리한신규한펙틴질다당류와그분리정제방법및그의면역증강제로서의용도
AU760669B2 (en) * 1998-04-28 2003-05-22 Galenica Pharmaceuticals, Inc. Polysaccharide-antigen conjugates
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
AU3837300A (en) * 1999-04-15 2000-11-02 Takara Shuzo Co., Ltd. Remedies
DE19940011B4 (de) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
NL1013175C2 (nl) * 1999-09-29 2001-03-30 Nutricia Nv Voedingssamenstellingen die niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
JP4024454B2 (ja) * 2000-03-31 2007-12-19 日本甜菜製糖株式会社 ＩｇＥ抗体産生低減剤およびアレルギー体質改善剤
AU2001264817A1 (en) * 2000-05-23 2001-12-17 Exhale Therapeutics, Inc. Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
DE10027050A1 (de) * 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
WO2002018614A1 (en) * 2000-08-30 2002-03-07 Amano Enzyme Inc. METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS
CN1111541C (zh) * 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
JP2002363082A (ja) * 2001-05-28 2002-12-18 Yoshiaki Nagaura ウィルスを不活化する方法
KR100450061B1 (ko) * 2001-06-13 2004-09-24 주식회사 한국인삼공사 홍삼으로부터 분리된 항암 면역 조절효과를 갖는 신규산성다당체 및 이를 함유하는 항암 면역 조절용 조성물
US20030078231A1 (en) * 2001-06-22 2003-04-24 Wilburn Michael D. Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties
US20030007961A1 (en) * 2001-06-22 2003-01-09 Wilburn Michael D. Orthomolecular vitamin E derivatives
JP4053743B2 (ja) * 2001-07-27 2008-02-27 株式会社ファンケル 免疫調節剤
JP2003221339A (ja) * 2002-01-29 2003-08-05 Oji Paper Co Ltd 抗炎症剤
ATE305309T1 (de) 2002-02-04 2005-10-15 Kyowa Hakko Kogyo Kk Pharmazeutische und lebenmittelzusammensetzungen mit einem di- oder oligosaccharid, das die insulinfreisetzung steigert
US20030180279A1 (en) * 2002-03-19 2003-09-25 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
PL1733730T3 (pl) 2003-10-24 2008-12-31 Nutricia Nv Oligosacharydy immunomodulujące

Also Published As

Publication number Publication date
US8557794B2 (en) 2013-10-15
SG152271A1 (en) 2009-05-29
CY1108342T1 (el) 2014-02-12
EP1675595A2 (en) 2006-07-05
CA2542996A1 (en) 2005-05-06
PL1721612T3 (pl) 2009-09-30
NZ577220A (en) 2011-01-28
PT1721612E (pt) 2009-09-02
AU2010235987A1 (en) 2010-11-11
EP1721612B1 (en) 2009-04-22
WO2005039597A3 (en) 2005-07-14
BRPI0415699A (pt) 2006-12-26
EP2305269A2 (en) 2011-04-06
RU2010102704A (ru) 2011-08-10
ES2781848T3 (es) 2020-09-08
EP2305269B1 (en) 2020-01-15
ATE429232T1 (de) 2009-05-15
WO2005039597A2 (en) 2005-05-06
PL1733730T3 (pl) 2008-12-31
JP2007525483A (ja) 2007-09-06
ES2324369T3 (es) 2009-08-05
EP1733730A2 (en) 2006-12-20
PT1733730E (pt) 2008-10-28
ES2309901T3 (es) 2008-12-16
RU2388478C2 (ru) 2010-05-10
NZ546785A (en) 2009-07-31
AU2004283628B2 (en) 2010-07-22
AU2004283628A2 (en) 2005-05-06
EP1733730A3 (en) 2006-12-27
RU2006117784A (ru) 2007-12-10
DE602004020809D1 (de) 2009-06-04
EP2305269A3 (en) 2011-07-13
EP1721612A3 (en) 2007-05-09
EP2223691A1 (en) 2010-09-01
US20070098762A1 (en) 2007-05-03
EP2123282A2 (en) 2009-11-25
DK1721612T3 (da) 2009-06-02
EP1733730B1 (en) 2008-07-09
JP4943853B2 (ja) 2012-05-30
DK1733730T3 (da) 2008-10-13
CA2542996C (en) 2014-05-27
ATE400278T1 (de) 2008-07-15
CN101987107A (zh) 2011-03-23
SG152270A1 (en) 2009-05-29
EP1911453A3 (en) 2008-09-03
SI1721612T1 (sl) 2009-08-31
EP1721612A2 (en) 2006-11-15
DE602004014992D1 (de) 2008-08-21
SI1733730T1 (sl) 2008-12-31
EP1935425A3 (en) 2008-09-03
EP1935425A2 (en) 2008-06-25
EP2123282A3 (en) 2010-01-20
EP1911453A2 (en) 2008-04-16
AU2004283628A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
CY1108342T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
DE60037578D1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
MX2007007781A (es) Composiciones cardiovasculares.
EP2332527A3 (en) Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
NO20060350L (no) Spebarns- eller smabarnssammensetninger
NO20072733L (no) Doseformer
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
EP1478371A4 (en) METHOD AND PRODUCTS FOR IMPROVING IMMUNE RESPONSES WITH IMIDAZOCHINOLINE COMPOUNDS
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
NO20076405L (no) Anvendelse av 24-nor-UDCA
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
WO2006002918A3 (de) Verwendung von trisubstituierten benzopyranonen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
BR0208554A (pt) Osteoprotegerina no leite
ZA200703237B (en) Pharmaceutical agents comprising blood components <10 KDA and their use for prophylaxis and treatment of defects of the immune system
WO2005107871A3 (en) Pyrroloquinoline quinone drugs for treatment of cardiac injury
ATE392150T1 (de) Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.